Clinical Trials
659
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (506 trials with phase data)• Click on a phase to view related trials
Injection Versus Suture Repair of Laryngeal Clefts
- Conditions
- Laryngeal CleftDysphagia
- First Posted Date
- 2025-07-09
- Last Posted Date
- 2025-07-09
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 128
- Registration Number
- NCT07057258
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸Vanderbilt University, Nashville, Tennessee, United States
Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults
- Conditions
- HealthyAging
- First Posted Date
- 2025-06-06
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 14
- Registration Number
- NCT07008300
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
- Conditions
- Chronic Pelvic Pain
- Interventions
- First Posted Date
- 2025-05-23
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 15
- Registration Number
- NCT06988319
Cannabis Association With Sleep Study
- Conditions
- Sleep
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 60
- Registration Number
- NCT06982950
Brief Sleep Intervention for Bedtime Resistance
- Conditions
- Child Sleep
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 40
- Registration Number
- NCT06970392
- Prev
- 1
- 2
- 3
- 4
- 5
- 132
- Next
News
Study Identifies Why Venetoclax-Based AML Treatment Fails in Certain Patients
Researchers analyzed 678 AML patients and found that both gene mutations and leukemia cell maturity affect response to venetoclax plus hypomethylating agents treatment.
Precede Biosciences Unveils Breakthrough Liquid Biopsy Platform for Tumor Gene Expression at AACR 2025
Precede Biosciences has developed a comprehensive epigenomic liquid biopsy platform capable of predicting expression of over 2,500 tumor-specific genes from just 1mL of blood plasma.
OB/GYN Workforce Shifts Following Abortion Bans: New Study Reveals Complex Migration Patterns
A new JAMA Network Open study reveals that while most OB/GYNs didn't immediately leave states with abortion bans after the 2022 Dobbs ruling, a significant decline is now occurring in the 12 most restrictive states.
Cancer Drug Use Rapidly Declines Following Withdrawal of FDA Accelerated Approval
A new study reveals significant decreases in oncology medication use after negative confirmatory trials are published, despite drugs remaining available for other indications.
NIH Launches CARE for Health Network to Enhance Primary Care Research
The NIH is investing $30 million to launch the CARE for Health network, aimed at integrating clinical research with community-based primary care.